Reliance Global Group reports news about its insurance and InsurTech operating foundation, financial results and strategic venture investments. Recurring company updates cover the RELI Exchange platform for independent insurance agencies, agency recruiting and productivity initiatives, and business updates tied to the company's insurance commission-based operations.
News also covers EZRA International Group and Reliance's ownership-driven investments in technology and life sciences. Recent themes include Enquantum's post-quantum cryptography platform, LifeSci Global's healthcare investment mandate, Innervate Radiopharmaceuticals' radiopharmaceutical development work, conference participation and governance or capital-allocation updates tied to the company's strategic ventures model.
Reliance Global Group (Nasdaq: XGPU) will hold its third-quarter 2026 results and business update call on November 16, 2026. The call starts at 4:30 PM Eastern Time. The company expects to issue its earnings release before the call and make it available on its investor relations website. Telephone and webcast access will be offered, with a webcast replay available through November 16, 2027.
Reliance Global Group (EZRA) will change its Nasdaq ticker to XGPU at the opening of trading on November 10, 2026. Its common stock will remain on The Nasdaq Capital Market, with its CUSIP unchanged; shareholders need take no action.
The company links the change to its entry into GPU cloud and AI infrastructure through the November 3, 2026 acquisition of Oblivus assets from Skyportal. The all-cash purchase was funded from cash on hand through its newly formed, wholly owned subsidiary, GPU Exchange. Reliance is adopting GPU Exchange as its doing-business-as name and the acquired business's brand, while retaining its legal name. It plans to scale GPU computing capacity and grow the marketplace while continuing to operate, enhance and grow RELI Exchange.
Reliance Global Group (Nasdaq: EZRA) completed its cash acquisition of Oblivus assets from Skyportal on November 3, 2026, entering AI infrastructure. The price includes $3,000,000 at closing and up to $750,000 contingent on revenue milestones during the following twelve months; $375,000 was placed in escrow. Cash on hand funded the acquisition, with no common shares issued as consideration, and Reliance remains debt-free.
Oblivus generated approximately $1.5 million in revenue during the twelve months ended September 2026, based on the seller’s unaudited records. Reliance plans to expand computing capacity and its GPU marketplace. A twelve-month founder consulting agreement adds $250,000 in cash and eligibility for up to $600,000 in common shares, largely conditional. Reliance plans the GPU Exchange brand and XGPU ticker; shares remain under EZRA pending a separately announced effective date.
Reliance Global Group (Nasdaq: EZRA) signed a non-binding letter of intent to acquire a GPU cloud provider and marketplace operator. Signed September 23, 2026, the proposed cash acquisition would bring Reliance into AI computing infrastructure without issuing shares; funding is already in place.
Terms call for $3,375,000 at closing, including $375,000 in escrow, plus $375,000 after 12 months. Both $375,000 payments depend on milestones. Founder consulting fees total $250,000 over the 12 months following closing. Due diligence is substantially complete; Reliance anticipates closing in early November 2026, subject to definitive agreements and closing conditions.
Reliance remains debt-free and plans to expand a company-owned graphics processing unit (GPU) fleet and the target's marketplace. It also plans the GPU Exchange brand and Nasdaq ticker XGPU; shares continue trading as EZRA pending a separately announced effective date.
Reliance Global Group (EZRA) has repaid its Oak Street Funding loan in full, eliminating all of its outstanding term debt. The loan balance was approximately $4.4 million as of June 30, 2026. After repayment, the company holds more than $6 million in cash.
The payoff used approximately $1.2 million from the Southwestern Montana Insurance Center sale, closed September 11, 2026; approximately $2.2 million from the Altruis Benefit Consulting sale, closed September 24, 2026; and approximately $1.0 million previously held as loan collateral. No shares were issued. Repayment eliminates approximately $1 million in annual principal, interest and service fee payments, including approximately $400,000 in interest and service fees.
Reliance Global Group (EZRA) completed the sale of substantially all Altruis Benefit Consulting assets for $8 million on September 23, 2026.
The company has received approximately $7.5 million in cash, including full payment of the buyer's $3.1 million secured promissory note on September 30. The buyer holds $461,729 as indemnity and working capital holdbacks. Reliance may earn up to $1 million over the three years following closing, based on annual revenue growth of the acquired business.
The sale involved no issuance of Reliance common stock and follows the September 11 sale of Southwestern Montana Insurance Center. Reliance plans to redeploy capital into its proprietary AI platform, RELI Exchange and other growth initiatives while continuing to evaluate its agency portfolio.
Reliance Global Group (EZRA) has completed the sale of its Southwestern Montana Insurance Center subsidiary for $2.625 million in cash at closing, plus an uncapped future earnout tied to EBITDA for the twelve months ending August 31, 2027.
The price reflects a multiple of 8.75 times pro forma EBITDA of $300,000, and no shares were issued, resulting in zero equity dilution. The deal closed on September 11, 2026, effective as of September 1, 2026, and is part of a portfolio monetization strategy launched in 2025 to divest non-core agencies, strengthen the balance sheet, accelerate term debt repayment, and redeploy capital into the RELI Exchange AI platform and other InsurTech growth initiatives.
Reliance Global Group (EZRA) has adopted a one-year stockholder rights plan effective September 3, 2026, which is intended to protect perceived undervalued stockholder interests against coercive or inadequate takeover attempts.
The rights plan expires on September 3, 2027, unless redeemed or terminated earlier. One right will be distributed for each share of common stock held as of the close of business on September 18, 2026, trading together with the common stock until the plan is triggered. The rights become exercisable if any person or group acquires 15% or more of the common stock without Board approval, while passive institutional investors may hold up to 20%. If triggered, all stockholders other than the acquiring person may buy additional shares at a significant discount, substantially diluting the acquirer.
Each right allows the purchase of one one-thousandth of a share of Series A Preferred Stock at $14.00 per one one-thousandth of a Preferred Share, subject to adjustment. The Board may redeem the rights at $0.001 per right before any person becomes an acquiring person, or later exchange each outstanding right (other than those of the acquirer) for one share of common stock. The plan contains no “dead-hand” provision and includes a “qualifying offer” feature allowing stockholders to call a special meeting to vote on redeeming rights in response to certain fully financed all-cash or all-stock offers.
Reliance Global Group (Nasdaq: EZRA) signed a non-binding letter of intent to sell the assets of its Altruis Benefit Consulting subsidiary, a Michigan-based health insurance agency and benefits consultancy, for $11 million in cash. Reliance would retain its proprietary AI platform, RELI Exchange and other insurance operations.
According to Reliance Global Group, about $9.35 million would be paid at closing and $1.65 million placed in an interest-bearing escrow, to be released 18 months after closing. The company expects to fully repay its approximately $4.4 million Oak Street Funding term loan, eliminating roughly $1 million in annual principal and interest expense, and to generate about $7.6 million of aggregate incremental cash (including $5 million net proceeds at closing before expenses and taxes, $1.0 million of released collateral cash, and $1.65 million from escrow). The all-cash structure implies zero equity dilution, and the parties are targeting closing within 60 days, subject to customary conditions, with proceeds intended to support investment in Reliance's AI platform and RELI Exchange InsurTech operations. The LOI remains non-binding and may not result in a completed transaction.
Reliance Global Group (Nasdaq: EZRA) reported 2026 Q2 results and highlighted acceleration of its proprietary AI platform for insurance operations. Commission income was approximately $2.1 million versus $3.1 million in Q2 2025, mainly due to earlier divestitures of non-core businesses, partially offset by organic growth in retained operations.
Operating expenses fell about 28% year-over-year, driven by lower commission expense, salaries and wages of $1.5 million (vs. $2.6 million), and general and administrative expenses of $1.2 million (vs. $1.5 million). Net loss improved to roughly $2.0 million from $2.7 million, while AEBITDA loss widened to about $1.1 million from $0.4 million. As of June 30, 2026, Reliance reported cash of $0.8 million, combined cash and restricted cash of $1.8 million, working capital of $1.2 million and stockholders’ equity of $6.6 million. The company launched a proprietary AI agent for secure browser automation and began deploying AI capabilities across its insurance operations.